Bank of America’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,250
Closed 7581
2019
Q1
$0 Hold
2,250
﹤0.01% 7594
2018
Q4
$0 Hold
2,250
﹤0.01% 7568
2018
Q3
$0 Hold
2,250
﹤0.01% 7592
2018
Q2
$0 Hold
2,250
﹤0.01% 7468
2018
Q1
$1K Hold
2,250
﹤0.01% 7022
2017
Q4
$1K Hold
2,250
﹤0.01% 6962
2017
Q3
$1K Hold
2,250
﹤0.01% 6981
2017
Q2
$1K Hold
2,250
﹤0.01% 6867
2017
Q1
$1K Buy
+2,250
New +$1.14K ﹤0.01% 6896

Bank of America's SNOAW Position: Q2 2019 in Review

Bank of America sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q2 2019, closing a stake of 2,250 shares.

Bank of America first reported a position in SNOAW in Q1 2017 and held it in 9 quarters. The position peaked at $1K in Q1 2018. 2 funds tracked by Wall St. Rank hold SNOAW as of Q2 2019.

  • Bank of America reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q2 2019 after selling out during the quarter.
  • Bank of America sold 2,250 Sonoma Pharmaceuticals, Inc. Warrants shares in Q2 2019.
  • Bank of America first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q1 2017 and held it in 9 quarters.
  • Bank of America's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $1K in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q2 2019.

Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.